|Bid||47.00 x 800|
|Ask||48.20 x 1000|
|Day's range||50.30 - 50.30|
|52-week range||33.00 - 65.90|
|Beta (5Y monthly)||0.77|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||72.67|
BOSTON, September 14, 2021--PureTech to Present at Oppenheimer Fall Healthcare Life Sciences and MedTech Summit
BOSTON, September 10, 2021--PureTech Founded Entity Vor Biopharma announced that the U.S. Food and Drug Administration has granted Fast Track designation to VOR33.
Every investor in PureTech Health plc ( LON:PRTC ) should be aware of the most powerful shareholder groups. Generally...